Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy ...

A woman's cancer seemed incurable. Identifying a rare genetic condition saved her life.

Chemo and surgery failed to treat Diane Davis' advanced cancer. Things seemed hopeless until genetic testing found an ...

IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer

Event being held today at 8:00 a.m. ET in New York City features presentations from Ovarian Cancer Key Opinion Leaders, Clinicians, Statistical ...

Targeted nanoparticles can jumpstart T cells, allowing them to attack ovarian tumors while avoiding side effects

Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...
EMBO Press

Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets

A deep spatial proteomic analysis of healthy fallopian tube epithelium, matching high-grade serous ovarian cancer (HGSOC) ...
Medscape

Brazil’s MasSpec Pen Finds Cancer in Real Time in 90 Seconds

Brazil is assessing the MasSpec Pen, a real-time cancer detection tool that identifies tumors in 90 seconds, to improve ...
The American Journal of Managed Care

Prospective Evidence Supports Tumor-First Multigene Testing in Ovarian Cancer

Multigene NGS on tumor tissue accurately identifies pathogenic variants in EOC, supporting a tumor-first genetic testing model. The study found 94.3% of tumors had detectable variants, with 99.1% ...

IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer

Webcast Recording and Symposium Slides Now AvailableLAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a ...
University of Chicago News

New ‘plug-and-play’ cell design could revolutionize cancer immunotherapy

To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
News Medical

Gamma knife radiosurgery shows high tumor control in brain metastases from ovarian cancer

Brain metastases from ovarian cancer (BMFOC) are rare but associated with poor prognosis. This study aimed to evaluate the efficacy and safety of Gamma Knife stereotactic radiosurgery (GKSRS) in ...